Stage III Lung Small Cell Carcinoma AJCC v7
specificStage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary
11
Centers
11
Active Trials
—
Cancer Funding
Top Centers for Stage III Lung Small Cell Carcinoma AJCC v7(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 54.5 |
| 2 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 54.5 |
| 3 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 54.5 |
| 4 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 54.5 |
| 5 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 54.5 |
| 6 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 54.5 |
| 7 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 54.5 |
| 8 | Boston University Cancer CenterBoston, MA Active Research Program | 54.5 |
| 9 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 54.5 |
| 10 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 54.5 |
| 11 | BC CancerVancouver, BC Active Research Program | 54.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →